Lexeo Therapeutics Inc (LXEO) Unusual Options Activity Today

Checking LXEO unusual options activity helps you spot when traders are making outsized bets on Lexeo Therapeutics Inc before the broader market catches on. Lexeo Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor LXEO unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching LXEO unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking LXEO unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and LXEO unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease.

The company was incorporated in 2017 and is based in New York, New York.

Catalysts rarely arrive without a footprint, and LXEO unusual options activity is often where that footprint shows up first. Our scanner tracks Lexeo Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at LXEO unusual options volume on the call side or chasing put sweeps, Lexeo Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.